Cargando…

Near Normalization of Metabolic and Functional Features of the Central Nervous System in Type 1 Diabetic Patients With End-Stage Renal Disease After Kidney-Pancreas Transplantation

OBJECTIVE: The pathogenesis of brain disorders in type 1 diabetes (T1D) is multifactorial and involves the adverse effects of chronic hyperglycemia and of recurrent hypoglycemia. Kidney-pancreas (KP), but not kidney alone (KD), transplantation is associated with sustained normoglycemia, improvement...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiorina, Paolo, Vezzulli, Paolo, Bassi, Roberto, Gremizzi, Chiara, Falautano, Monica, D’Addio, Francesca, Vergani, Andrea, Chabtini, Lola, Altamura, Erica, Mello, Alessandra, Caldara, Rossana, Scavini, Marina, Magnani, Giuseppe, Falini, Andrea, Secchi, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263904/
https://www.ncbi.nlm.nih.gov/pubmed/22190674
http://dx.doi.org/10.2337/dc11-1697
_version_ 1782221947858321408
author Fiorina, Paolo
Vezzulli, Paolo
Bassi, Roberto
Gremizzi, Chiara
Falautano, Monica
D’Addio, Francesca
Vergani, Andrea
Chabtini, Lola
Altamura, Erica
Mello, Alessandra
Caldara, Rossana
Scavini, Marina
Magnani, Giuseppe
Falini, Andrea
Secchi, Antonio
author_facet Fiorina, Paolo
Vezzulli, Paolo
Bassi, Roberto
Gremizzi, Chiara
Falautano, Monica
D’Addio, Francesca
Vergani, Andrea
Chabtini, Lola
Altamura, Erica
Mello, Alessandra
Caldara, Rossana
Scavini, Marina
Magnani, Giuseppe
Falini, Andrea
Secchi, Antonio
author_sort Fiorina, Paolo
collection PubMed
description OBJECTIVE: The pathogenesis of brain disorders in type 1 diabetes (T1D) is multifactorial and involves the adverse effects of chronic hyperglycemia and of recurrent hypoglycemia. Kidney-pancreas (KP), but not kidney alone (KD), transplantation is associated with sustained normoglycemia, improvement in quality of life, and reduction of morbidity/mortality in diabetic patients with end-stage renal disease (ESRD). RESEARCH DESIGN AND METHODS: The aim of our study was to evaluate with magnetic resonance imaging and nuclear magnetic resonance spectroscopy ((1)H MRS) the cerebral morphology and metabolism of 15 ESRD plus T1D patients, 23 patients with ESRD plus T1D after KD (n = 9) and KP (n = 14) transplantation, and 8 age-matched control subjects. RESULTS: Magnetic resonance imaging showed a higher prevalence of cerebrovascular disease in ESRD plus T1D patients (53% [95% CI 36–69]) compared with healthy subjects (25% [3–6], P = 0.04). Brain (1)H MRS showed lower levels of N-acetyl aspartate (NAA)-to-choline ratio in ESRD plus T1D, KD, and KP patients compared with control subjects (control subjects vs. all, P < 0.05) and of NAA-to-creatine ratio in ESRD plus T1D compared with KP and control subjects (ESRD plus T1D vs. control and KP subjects, P ≤ 0.01). The evaluation of the most common scores of psychological and neuropsychological function showed a generally better intellectual profile in control and KP subjects compared with ESRD plus T1D and KD patients. CONCLUSIONS: Diabetes and ESRD are associated with a precocious form of brain impairment, chronic cerebrovascular disease, and cognitive decline. In KP-transplanted patients, most of these features appeared to be near normalized after a 5-year follow-up period of sustained normoglycemia.
format Online
Article
Text
id pubmed-3263904
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-32639042013-02-01 Near Normalization of Metabolic and Functional Features of the Central Nervous System in Type 1 Diabetic Patients With End-Stage Renal Disease After Kidney-Pancreas Transplantation Fiorina, Paolo Vezzulli, Paolo Bassi, Roberto Gremizzi, Chiara Falautano, Monica D’Addio, Francesca Vergani, Andrea Chabtini, Lola Altamura, Erica Mello, Alessandra Caldara, Rossana Scavini, Marina Magnani, Giuseppe Falini, Andrea Secchi, Antonio Diabetes Care Original Research OBJECTIVE: The pathogenesis of brain disorders in type 1 diabetes (T1D) is multifactorial and involves the adverse effects of chronic hyperglycemia and of recurrent hypoglycemia. Kidney-pancreas (KP), but not kidney alone (KD), transplantation is associated with sustained normoglycemia, improvement in quality of life, and reduction of morbidity/mortality in diabetic patients with end-stage renal disease (ESRD). RESEARCH DESIGN AND METHODS: The aim of our study was to evaluate with magnetic resonance imaging and nuclear magnetic resonance spectroscopy ((1)H MRS) the cerebral morphology and metabolism of 15 ESRD plus T1D patients, 23 patients with ESRD plus T1D after KD (n = 9) and KP (n = 14) transplantation, and 8 age-matched control subjects. RESULTS: Magnetic resonance imaging showed a higher prevalence of cerebrovascular disease in ESRD plus T1D patients (53% [95% CI 36–69]) compared with healthy subjects (25% [3–6], P = 0.04). Brain (1)H MRS showed lower levels of N-acetyl aspartate (NAA)-to-choline ratio in ESRD plus T1D, KD, and KP patients compared with control subjects (control subjects vs. all, P < 0.05) and of NAA-to-creatine ratio in ESRD plus T1D compared with KP and control subjects (ESRD plus T1D vs. control and KP subjects, P ≤ 0.01). The evaluation of the most common scores of psychological and neuropsychological function showed a generally better intellectual profile in control and KP subjects compared with ESRD plus T1D and KD patients. CONCLUSIONS: Diabetes and ESRD are associated with a precocious form of brain impairment, chronic cerebrovascular disease, and cognitive decline. In KP-transplanted patients, most of these features appeared to be near normalized after a 5-year follow-up period of sustained normoglycemia. American Diabetes Association 2012-02 2012-01-16 /pmc/articles/PMC3263904/ /pubmed/22190674 http://dx.doi.org/10.2337/dc11-1697 Text en © 2012 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Original Research
Fiorina, Paolo
Vezzulli, Paolo
Bassi, Roberto
Gremizzi, Chiara
Falautano, Monica
D’Addio, Francesca
Vergani, Andrea
Chabtini, Lola
Altamura, Erica
Mello, Alessandra
Caldara, Rossana
Scavini, Marina
Magnani, Giuseppe
Falini, Andrea
Secchi, Antonio
Near Normalization of Metabolic and Functional Features of the Central Nervous System in Type 1 Diabetic Patients With End-Stage Renal Disease After Kidney-Pancreas Transplantation
title Near Normalization of Metabolic and Functional Features of the Central Nervous System in Type 1 Diabetic Patients With End-Stage Renal Disease After Kidney-Pancreas Transplantation
title_full Near Normalization of Metabolic and Functional Features of the Central Nervous System in Type 1 Diabetic Patients With End-Stage Renal Disease After Kidney-Pancreas Transplantation
title_fullStr Near Normalization of Metabolic and Functional Features of the Central Nervous System in Type 1 Diabetic Patients With End-Stage Renal Disease After Kidney-Pancreas Transplantation
title_full_unstemmed Near Normalization of Metabolic and Functional Features of the Central Nervous System in Type 1 Diabetic Patients With End-Stage Renal Disease After Kidney-Pancreas Transplantation
title_short Near Normalization of Metabolic and Functional Features of the Central Nervous System in Type 1 Diabetic Patients With End-Stage Renal Disease After Kidney-Pancreas Transplantation
title_sort near normalization of metabolic and functional features of the central nervous system in type 1 diabetic patients with end-stage renal disease after kidney-pancreas transplantation
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263904/
https://www.ncbi.nlm.nih.gov/pubmed/22190674
http://dx.doi.org/10.2337/dc11-1697
work_keys_str_mv AT fiorinapaolo nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation
AT vezzullipaolo nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation
AT bassiroberto nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation
AT gremizzichiara nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation
AT falautanomonica nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation
AT daddiofrancesca nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation
AT verganiandrea nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation
AT chabtinilola nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation
AT altamuraerica nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation
AT melloalessandra nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation
AT caldararossana nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation
AT scavinimarina nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation
AT magnanigiuseppe nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation
AT faliniandrea nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation
AT secchiantonio nearnormalizationofmetabolicandfunctionalfeaturesofthecentralnervoussystemintype1diabeticpatientswithendstagerenaldiseaseafterkidneypancreastransplantation